companydata.dkGALECTO BIOTECH ApS: Financial statements 2022
CVR: 34878366
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 12,287,141 and a net result of DKK 818,741 compared with DKK 764,793 the year before. That is an increase of 30.6% compared with the year before. Equity amounted to DKK 7,394,015. The solvency ratio was 74.7%. The company had 36 employees in the financial year.
- Gross Profit
- 12,287,141 kr.
- Profit/Loss
- 818,741 kr.
- Equity
- 7,394,015 kr.
- Total Assets
- 9,898,978 kr.
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 12.3 mio. | 819 t. | 7.4 mio. | 36 |
| 2021 | - | 9.4 mio. | 765 t. | 3.7 mio. | 29 |
| 2020 | - | 4.9 mio. | 214 t. | 2.9 mio. | 16 |
| 2019 | - | 2.4 mio. | 324 t. | 2.7 mio. | 11 |
| 2018 | - | -2.6 mio. | -3.7 mio. | -12.8 mio. | 5 |
Keep an eye on GALECTO BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GALECTO BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 9,406,910, and the net result was DKK 764,793.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees. In 2024, the company reported a gross profit of DKK 5,477,168 and a net result of DKK 310,297 compared with DKK 849,392 the year before. Equity amounted to DKK 8,553,704.